Cencora (NYSE:COR) executives said the company expects its specialty-focused strategy to support continued growth into fiscal 2027, citing demand in oncology and retina, expanded physician-services capabilities and momentum in its international businesses. Speaking at the Morgan Stanley Global Healthcare Conference, Chief Executive Officer Bob Mauch said the company’s recent growth has reflected its position in […]